Friday, January 4, 2013

11 Healthcare Stocks for Dividend Lovers

Healthcare is one of the fastest growing industries in the world. The annual growth rate of total expenditures on healthcare is 7.1% between 2000-2008 in the United States. Average annual growth in National Health Expenditures (NHE) for 2009 through 2019 is expected to be 6.3%. NHE as a share of Gross Domestic Product (GDP) is expected to be 19.6% by 2019.

We prepared a list of eleven Healthcare companies which pay fat dividend checks regularly. All companies in this list have a dividend yield of at least 3.5%. These eleven stocks returned 9.64% (including dividends) during the past 12 months, beating the government bonds by a large margin.

1- AstraZeneca PLC (AZN): AstraZeneca is one of the leading biopharmaceutical companies in the world. AZN recently traded at $46.22 and has a 5.52% dividend yield. AZN gained 9.34% during the past 12 months. The stock has a market cap of $68 billion and P/E ratio of 8.3.

2- GlaxoSmithKline plc (GSK): GlaxoSmithKline is one of the major drug manufacturers in the world. GSK recently traded at $37.62 and has a 5.42% dividend yield. GSK gained 2.73% during the past 12 months. The stock has a market cap of $97 billion and P/E ratio of 36.4. Warren Buffett has GSK in his portfolio.

3- Shamir Optical Industry, Ltd. (SHMR): Shamir Optical Industry is a medical appliances and equipment company which is operating in Israel. SHMR recently traded at $13.85 and has a 5.81% dividend yield. SHMR gained 57.03% during the past 12 months. The stock has a market cap of $230 million and P/E ratio of 15.2.

4- Eli Lilly & Co. (LLY): Eli Lilly is one of the major drug manufacturers in the world. LLY recently traded at $34.36 and has a 5.7% dividend yield. LLY gained 0.09% during the past 12 months. The stock has a market cap of $38 billion and P/E ratio of 7.5.

5- Psychemedics Corp. (PMD): Psychemedics is providing testing services for the detection of abused substances in the United States. PMD recently traded at $9.3 and has a 5.16% dividend yield. PMD gained 25.85% during the past 12 months. The stock has a market cap of $45 million and P/E ratio of 17.9.

6- Emergent Group, Inc. (LZR): Emergent Group provides surgical equipment to hospitals, surgical care centers, and other health care providers in the United States. LZR recently traded at $8.45 and has a 4.74% dividend yield. LZR gained 13.12% during the past 12 months. The stock has a market cap of $58,2 million and P/E ratio of 18.8.

7- Merck & Co. Inc. (MRK): Merck & Co., Inc., is a global health care company. MRK recently traded at $32.63 and has a 4.66% dividend yield. MRK lost 10.33% during the past 12 months. The stock has a market cap of $100 billion and P/E ratio of 116.5. David Tepper's Appaloosa has MRK in its portfolio.

8- Pfizer Inc. (PFE): Pfizer is one of the leading biopharmaceutical companies in the world. PFE recently traded at $19.92 and has a 3.71% dividend yield. PFE gained 18.01% during the past 12 months. The stock has a market cap of $153 billion and P/E ratio of 19.5. Lee Ainslie's Maverick, David Einhorn's Greenlight, Curtis Schenker's Scoggin, and Roberto Mignone's Bridger have PFE in their portfolios.

9- Abbott Laboratories (ABT): Abbott Laboratories is one of the major drug manufacturers in the world. ABT recently traded at $47.99 and has a 3.67% dividend yield. ABT lost 7.73% during the past 12 months. The stock has a market cap of $74 billion and P/E ratio of 16.2. Jim Simons has ABT in his portfolio.

10- Johnson & Johnson (JNJ): Johnson & Johnson is one of the major drug manufacturers in the world. JNJ recently traded at $58.72 and has a 3.68% dividend yield. JNJ lost 5.99% during the past 12 months. The stock has a market cap of $166 billion and P/E ratio of 12.3. Warren Buffett, David Tepper, and Jim Simons have JNJ in their portfolio's.

11- Meridian Bioscience Inc. (VIVO): Meridian Bioscience is an integrated life science company. VIVO recently traded at $21.37 and has a 3.56% dividend yield. VIVO gained 3.94% during the past 12 months. The stock has a market cap of $877 million and P/E ratio of 36.8.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

No comments:

Post a Comment